About Brainsbioceutical
Brainsbioceutical is a company based in Vancouver (Canada). Brainsbioceutical has raised $61.9 million across 2 funding rounds from investors including dsm-firmenich, Canaccord Genuity Group and Cannabis Europe.
- Headquarter Vancouver, Canada
-
Sectors
Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$61.9 M (USD)
in 2 rounds
-
Latest Funding Round
$31.9 M (USD), Series B
Jun 16, 2021
-
Investors
dsm-firmenich
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Brainsbioceutical
Brainsbioceutical has successfully raised a total of $61.9M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31.9 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Brainsbioceutical
Brainsbioceutical has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include dsm-firmenich, Canaccord Genuity Group and Cannabis Europe.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health, nutrition, and bioscience solutions are delivered worldwide.
|
Locked | Locked | Locked | |
|
Merger and acquisitions advisory firm
|
Locked | Locked | Locked | |
|
Cannabis Europe is recognized as an advocacy group for medical cannabis.
|
Locked | Locked | Locked |
Investor details for Brainsbioceutical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brainsbioceutical
Investment portfolio details for Brainsbioceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brainsbioceutical
Detailed financials for Brainsbioceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainsbioceutical Comparisons
Peer comparison for Brainsbioceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brainsbioceutical
Detailed competitors of Brainsbioceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainsbioceutical
Complete news archive for Brainsbioceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brainsbioceutical
Brainsbioceutical is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Rick Brar is the current CEO of Brainsbioceutical.
Brainsbioceutical is a funded company, having raised a total of $61.9M across 2 funding rounds to date.
Pharmaceutical-grade cannabinoid active pharmaceutical ingredients are produced by Brainsbioceutical in Vancouver, Canada, for the pharmaceutical and nutraceutical sectors. These ingredients are derived from natural sources. Relevant licenses and certifications are maintained to meet industry standards. A selection of cannabinoid APIs, including CBD and associated compounds, is supplied. Research and development activities are pursued to support cannabinoid applications in medicine.
Brainsbioceutical has 3 investors. Key investors include dsm-firmenich, Canaccord Genuity Group, and Cannabis Europe.